Blastic natural killer (NK) cell lymphoma (also termed CD4+ CD56+ hematodermic
neoplasm) is a recently described entity, with the first case reported in 1994. It was …

Described herein is the evolution in the diagnosis and classification of tumors that are
variously known as blastic or blastoid natural killer cell lymphoma, CD4+/CD56+ …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a neoplasm derived from
precursors of plasmacytoid dendritic cells. Cutaneous involvement represents often the first …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) represents the
malignant counterpart derived from plasmacytoid dendritic cells. This rare entity is usually …

A new entity of acute leukemia coexpressing CD4+ CD56+ markers without any other
lineage-specific markers has been identified recently as arising from lymphoid-related …

Agranular CD4/CD56 hematodermic neoplasm (CD4/CD56 HN), also termed blastic natural
killer cell lymphoma, is characterized by a peculiar immunophenotype and high skin tropism …

Natural killer (NK) cell tumors are an uncommon and heterogeneous group of disorders. The
World Health Organization (WHO) classified mature NK cell neoplasms into 2 types: 1) …

Summary CD4+/CD56+ haematodermic neoplasm or 'early'plasmacytoid dendritic cell
leukaemia/lymphoma (pDCL) was described as a disease entity in the last World Health …

Abstract G-CSF primed CD34 cells cultured for 2–3 weeks in IL-2 and stem cell factor
generate CD56 high cells with phenotypic and morphologic features of NK cells, and a novel …

Dendritic cells (DC), considered as immunological sentinels of the organism since they are
antigen presenting cells, create the link between innate and adaptive immunity. DC include …